Axsome Therapeutics, Inc.·4

Feb 29, 6:18 PM ET

Mahony Susan 4

4 · Axsome Therapeutics, Inc. · Filed Feb 29, 2024

Insider Transaction Report

Form 4
Period: 2024-02-27
Mahony Susan
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-02-27+191191 total
    Exercise: $84.00From: 2024-02-27Exp: 2034-02-26Common Stock (191 underlying)
Footnotes (1)
  • [F1]Represents 191 options elected to be received in lieu of cash compensation earned in 2023. All of such options are immediately exercisable.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4